Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» graft vs host disease
graft vs host disease
Equillium's EQ001 Granted FDA Fast Track Designation for Acute Graft-Versus-Host Disease
CP Wire
Wed, 12/19/18 - 10:36 am
Equillium
graft vs host disease
EQ001
Equillium's EQ001 Granted FDA Fast Track Designation for Acute Graft-Versus-Host Disease
Wed, 12/19/18 - 10:15 am
Equillium
graft vs host disease
FDA Grants Priority Review for Ruxolitinib (Jakafi) for Acute Graft-Versus-Host Disease
CP Wire
Thu, 10/25/18 - 09:52 am
FDA
Incyte
Novartis
Jakavi
Jakafi
graft vs host disease
FDA Grants Priority Review for Ruxolitinib (Jakafi) for Acute Graft-Versus-Host Disease
Thu, 10/25/18 - 09:35 am
Incyte
graft vs host disease
Novartis
Jakafi
Incyte preps Jakafi expansion into graft-versus-host disease
Biopharma Dive
Thu, 06/21/18 - 11:00 pm
Incyte
Jakafi
graft vs host disease
J&J, AbbVie's Imbruvica breaks out of blood-cancer corner with new graft-versus-host approval
Fierce Pharma
Wed, 08/2/17 - 09:33 pm
JNJ
AbbVie
Imbruvica
graft vs host disease
FDA
Kamada slumps after Shire hands back rights
BioPharma Dive
Thu, 06/8/17 - 10:05 pm
Shire
Kamada
alpha-1 antitrypsin
graft vs host disease
AbbVie Is Focused on Label Expansion of Imbruvica in 2017
Market Realist
Tue, 05/2/17 - 11:22 am
AbbVie
Imbruvica
non-Hodgkin's lymphoma
mantle cell lymphoma
graft vs host disease
AbbVie Inc Bags Fourth Breakthrough Therapy Status for Imbruvica
Bidness, ETC
Thu, 06/30/16 - 09:35 am
AbbVie
breakthrough therapies
Imbruvica
cGVHD
graft vs host disease
FDA Grants Breakthrough Therapy Designation for Incyte’s Ruxolitinib (Jakafi®) in Acute Graft-Versus-Host Disease (GVHD)
Yahoo
Fri, 06/24/16 - 09:15 am
FDA
Incyte
Jakafi
breakthrough therapies
graft vs host disease
$35M deal: Incyte licenses Lilly drug for potential new use
Bizjournals.com
Wed, 04/6/16 - 10:20 pm
Incyte
Eli Lilly
ruxolitinib
graft vs host disease
Firm to seek 1st approval for stem cell-based medicine in Japan
The Japan News
Mon, 12/30/13 - 11:20 am
stem cells
JCR Pharmaceutical
graft vs host disease
Pluristem's Promising GvHD Indication Pits It Against Osiris
Seeking Alpha
Tue, 10/8/13 - 08:41 am
Pluristem
graft vs host disease
Osiris
stem cells
Another Nod for Osiris' Prochymal
Yahoo/Zacks.com
Mon, 06/18/12 - 09:23 pm
Osiris
Prochymal
graft vs host disease
New Zealand approves Osiris stem cell therapy
Yahoo/AP
Sat, 06/16/12 - 12:47 pm
Osiris Therapeutics
Prochymal
stem cells
graft vs host disease
Osiris Provides Update on Sanofi Deal
Yahoo/Zacks
Sat, 02/11/12 - 11:40 am
Osiris Therapeutics
Sanofi
Prochymal
graft vs host disease
Soligenix shares decimated on repeat failure for orBec Ph3
Fierce Biotech
Thu, 09/15/11 - 12:26 pm
orBec
Soligenix
graft vs host disease
Athersys Releases Encouraging Results for Single Dose Arm of MultiStem
Seeking Alpha
Thu, 05/26/11 - 12:30 pm
Athersys
MultiStem
graft vs host disease
Osiris gets Canadian request on Prochymal
Yahoo/AP
Sat, 01/15/11 - 12:19 pm
Osiris
Prochymal
stem cells
graft vs host disease
Pages
« first
‹ previous
1
2
3